Skip to main content

Table 1 Characteristics of exposed individuals at the initial visit

From: Prophylaxis by doravirine-lamivudine-tenofovir disoproxil fumarate or elvitegravir-cobicistat-emtricitabine-tenofovir alafenamide after sexual exposure to HIV

 

EVG/c/FTC/TAF

DOR/3TC/TDF

p-value

n = 171

n = 140

 

Age, median (min–max)

30 (18–75)

29 (18–70)

0.80

Male

150 (87.7%)

115 (82.1%)

0.17

Previous HIV non-occupational exposure

64 (37.4%)

31 (22.1%)

0.03

HIV-infected source subject

8 (4.7%)

6 (4.3%)

1

Previous sexually transmitted diseases

27 (15.8%)

29 (20.7%)

0.26

Condom:

 No condom use

85 (50.3%)

77 (56.6%)

 

 Slippage of the condom

14 (8.3%)

4 (2.9%)

 

 Condom breakage

70 (41.4%)

53 (39.0%)

 

 Use of condom

0

2 (1.5%)

 

Type of exposure: MSM (men who have sex with men)

110 (74.3%)

91 (81.3%)

0.23

Use of chemsex

18 (10.5%)

14 (10.0%)

0.87

Type of sex:

 Insertive anal

32 (18.9%)

43 (31.6%)

 

 Receptive anal

70 (41.4%)

47 (34.6%)

 

 Insertive oral sex

3 (1.8%)

0

 

 Receptive oral sex

7 (4.1%)

6 (4.3%)

 

 Receptive or insertive vaginal

53 (31.4%)

39 (28.7%)

 

 Others

4 (2.4%)

1 (0.7%)